Validation of the Polish Fatigue Severity Scale
Validation of Polish Language Version of Fatigue Severity Scale
This study is testing a Polish version of a questionnaire to see how well it measures fatigue in people with multiple sclerosis, ALS, and stroke.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 310 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Jagiellonian University Academic / other |
| Locations | 2 sites (Krakow, Lesser Poland Voivodeship and 1 other locations) |
| Trial ID | NCT06668649 on ClinicalTrials.gov |
What this trial studies
This study aims to validate the Polish-language version of the Fatigue Severity Scale (pFSS), a tool designed to assess the impact of fatigue on patients' lives, particularly those suffering from multiple sclerosis, amyotrophic lateral sclerosis, and stroke. The pFSS is a nine-item self-report questionnaire that uses a Likert scale to measure fatigue severity. The validation process includes translation by bilingual experts and pretesting on patients to ensure accuracy and reliability. By establishing a validated tool in Polish, the study seeks to improve the assessment of fatigue in Polish-speaking patients with these conditions.
Who should consider this trial
Good fit: Ideal candidates for this study include individuals diagnosed with multiple sclerosis, amyotrophic lateral sclerosis, ischemic stroke, or healthy controls without conditions that induce abnormal tiredness.
Not a fit: Patients with cognitive deficits or behavioral disorders that could interfere with their participation in the study may not benefit from this research.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and management of fatigue in patients with multiple sclerosis, amyotrophic lateral sclerosis, and stroke, ultimately improving their quality of life.
How similar studies have performed: Previous studies have successfully validated the Fatigue Severity Scale in multiple languages, indicating a strong foundation for this Polish version.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of definite multiple sclerosis or definite, laboratory-supported multiple sclerosis, or definite amyotrophic lateral sclerosis, or probable amyotrophic lateral sclerosis or probable, laboratory supported amyotrophic lateral sclerosis or ischemic stroke or - for healthy controls - lack of diseases, pharmacotherapy or habits, which could induce abnormal tiredness Exclusion Criteria: * Presence of cognitive deficits or behavioral disorder, which could disturb participation in the study.
Where this trial is running
Krakow, Lesser Poland Voivodeship and 1 other locations
- Jagiellonian University Medical College, Department of Neurology — Krakow, Lesser Poland Voivodeship, Poland (Recruiting)
- Institute of Psychiatry and Neurology — Warsaw, Poland (Recruiting)
Study contacts
- Principal investigator: Jakub M Antczak, MD — Jagiellonian University
- Study coordinator: Jakub M Antczak, MD
- Email: jakub.antczak@uj.edu.pl
- Phone: +48 12 400 25 50
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.